Livzon Pharma Sets 12 November 2026 EGM to Decide on Board Appointment, Q3 2026 Profit Distribution and 2026-2028 Return Plan

Bulletin Express
10/23

Livzon Pharmaceutical Group Inc. (Livzon Pharma) has issued a proxy form for its 2026 Second Extraordinary General Meeting (EGM), scheduled for 12 November 2026 at 2:00 p.m. in the company’s headquarters conference room, 6th Floor, 38 Chuangye North Road, Jinwan District, Zhuhai, Guangdong Province, China.

Shareholders will be asked to vote on three ordinary resolutions:

1. Appointment of Ms. Zhu Linlin as a non-executive director. 2. Approval of the Profit Distribution Plan for the third quarter of 2026. 3. Approval of the Shareholder Return Plan for the next three years (2026-2028).

All shareholders are entitled to attend or to appoint one or more proxies. Completed proxy forms and any related authorisations must reach the Board Secretariat (A-shareholders) or Tricor Investor Services Limited (H-shareholders) no later than 24 hours before the meeting. Completion of the proxy form does not preclude shareholders from attending and voting in person; attendance in person will automatically revoke any submitted proxy.

Votes will be tallied with “For,” “Against,” and “Abstain” options. Any abstention will be counted in the calculation of the required majority, while votes cast in contravention of Hong Kong Stock Exchange rules will be disregarded.

The meeting underscores Livzon Pharma’s upcoming governance adjustment and planned capital-return framework covering the near-term profit distribution and a three-year shareholder return roadmap.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10